Clinical Trial Update: A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 safety study of pazopanib eye drops in healthy volunteers has completed. The trial pertained to ocular use in the context of age-related macular degener…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Pazopanib eye drops (pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Macular Degeneration | Phase 1 | Status: COMPLETED